HIGH-GRADE B-CELL LYMPHOMA (HGBCL)
Clinical trials for HIGH-GRADE B-CELL LYMPHOMA (HGBCL) explained in plain language.
Never miss a new study
Get alerted when new HIGH-GRADE B-CELL LYMPHOMA (HGBCL) trials appear
Sign up with your email to follow new studies for HIGH-GRADE B-CELL LYMPHOMA (HGBCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a simple vaccine boost immunity in CAR T-Cell patients?
Disease control OngoingThis study looks at whether giving a pneumococcal vaccine (PCV13) before and after CAR T-cell therapy can improve the body's ability to fight off pneumococcus bacteria. It involves 26 adults with certain types of lymphoma who are scheduled for CAR T-cell treatment. The main goal …
Matched conditions: HIGH-GRADE B-CELL LYMPHOMA (HGBCL)
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New antibody therapy shows promise for Tough-to-Treat lymphomas
Disease control OngoingThis study tests a new drug called epcoritamab (GEN3013) in people with B-cell lymphoma that has come back or stopped responding to treatment. The drug is an antibody that helps the immune system attack cancer cells. The trial aims to find the best dose, check for side effects, a…
Matched conditions: HIGH-GRADE B-CELL LYMPHOMA (HGBCL)
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated May 20, 2026 11:55 UTC